Technology | June 18, 2015

Toshiba Gains FDA Clearance for Aquilion ONE Family Enhancements

Software and hardware upgrades focus on increased patient safety

Toshiba, Aquilion ONE, enhancements, FDA, patient safety

June 18, 2015 - Toshiba America Medical Systems Inc. has received U.S. Food and Drug Administration (FDA) clearance for detector and computed tomography (CT) software enhancements for its Aquilion ONE family of CT systems.

Toshiba emphasizes patient safety in its latest software and hardware enhancements, including:

  • AIDR 3D Enhanced: Toshiba's fourth generation of advanced iterative noise reduction algorithm;
  • PUREViSION CT Detector: This more efficient CT detector results in 40 percent better light output for better use of X-ray photons;
  • SUREkV: Provides automated kV selection based on patient size;
  • Organ Effective Modulation: Delivers safer exams for both patients and providers by limiting dose to radiosensitive organs and during helical scanning and CT fluoroscopy procedures;
  • Contrast Management: Improves workflow and safety by standardizing contrast protocols and automatically tracking volume of contrast used during an exam; and
  • Power Save Mode: Sleep mode option decreases energy consumption when CT system is not in use.

 

For more information: www.medical.toshiba.com

Related Content

Image courtesy of Philips Healthcare

News | Clinical Trials | July 19, 2018
The use of computed tomography (CT) scans has increased dramatically over the last two decades. CT scans greatly...
CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.

News | Clinical Decision Support | July 18, 2018
A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt...
Study Shows Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers
News | Lung Cancer | July 16, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon...
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
The images (before and after) depict a 50 percent dose reduction in chest X-ray without compromising  image quality.

The images (before) depict a 50 percent dose reduction in chest X-ray without compromising
image quality.

Sponsored Content | Case Study | Radiation Dose Management | July 03, 2018
There are a handful of priorities for radiologists: lowest radiation dosage, highest image quality, optimal workflow,...
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Peter Juodka, RT(CT) operates the 16-slice Siemens Somatom Scope CT scanner in the mobile stroke unit to assess stroke patients immediately at the call site.

Peter Juodka, RT(CT) operates the 16-slice Siemens Somatom Scope CT scanner in the mobile stroke unit to assess stroke patients immediately at the call site.

Feature | Computed Tomography (CT) | July 03, 2018 | By Jeff Zagoudis
Stroke is the fifth leading cause of death in the United States, responsible for more than 140,000 deaths in some of
Overlay Init